158 related articles for article (PubMed ID: 29037461)
1. Sustained improvement in vancomycin dosing and monitoring post-implementation of guidelines: Results of a three-year follow-up after a multifaceted intervention in an Australian teaching hospital.
Phillips CJ; McKinnon RA; Woodman RJ; Gordon DL
J Infect Chemother; 2018 Feb; 24(2):103-109. PubMed ID: 29037461
[TBL] [Abstract][Full Text] [Related]
2. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist-led implementation of a vancomycin guideline across medical and surgical units: impact on clinical behavior and therapeutic drug monitoring outcomes.
Phillips CJ; Gordon DL
Integr Pharm Res Pract; 2015; 4():145-152. PubMed ID: 29354529
[TBL] [Abstract][Full Text] [Related]
4. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring.
Swartling M; Gupta R; Dudas V; Guglielmo BJ
Int J Clin Pharm; 2012 Apr; 34(2):282-5. PubMed ID: 22331444
[TBL] [Abstract][Full Text] [Related]
5. A pre-postintervention study to evaluate the impact of dose calculators on the accuracy of gentamicin and vancomycin initial doses.
Hamad A; Cavell G; Hinton J; Wade P; Whittlesea C
BMJ Open; 2015 Jun; 5(6):e006610. PubMed ID: 26044758
[TBL] [Abstract][Full Text] [Related]
6. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
Xu G; Chen E; Mao E; Che Z; He J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
[TBL] [Abstract][Full Text] [Related]
7. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S
Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376
[TBL] [Abstract][Full Text] [Related]
9. Barriers and facilitators of appropriate vancomycin use: prescribing context is key.
Chan JOS; Baysari MT; Carland JE; Sandaradura I; Moran M; Day RO
Eur J Clin Pharmacol; 2018 Nov; 74(11):1523-1529. PubMed ID: 30056569
[TBL] [Abstract][Full Text] [Related]
10. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
[TBL] [Abstract][Full Text] [Related]
11. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
12. Importance of Decision Support Implementation in Emergency Department Vancomycin Dosing.
Faine B; Mohr N; Harland KK; Rolfes K; Porter B; Fuller BM
West J Emerg Med; 2015 Jul; 16(4):557-64. PubMed ID: 26265968
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
14. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.
Kullar R; Davis SL; Taylor TN; Kaye KS; Rybak MJ
Pharmacotherapy; 2012 Mar; 32(3):195-201. PubMed ID: 22392452
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Pediatric-Specific Vancomycin Dosing Guidelines: A Quality Improvement Initiative.
Miloslavsky M; Galler MF; Moawad I; Actis J; Cummings BM; El Saleeby CM
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562258
[TBL] [Abstract][Full Text] [Related]
17. The Scottish model of vancomycin dosing and therapeutic drug monitoring improves both efficacy and safety of vancomycin therapy.
Zahálková K; Chrdle A; Dvořáčková O; Kašparová M; Horníková M; Chmelík V
Vnitr Lek; 2018; 64(7-8):717-724. PubMed ID: 30441978
[TBL] [Abstract][Full Text] [Related]
18. Improvement in vancomycin utilization in adults in a Saudi Arabian Medical Center using the Hospital Infection Control Practices Advisory Committee guidelines and simple educational activity.
Dib JG; Al-Tawfiq JA; Al Abdulmohsin S; Mohammed K; Jenden PD
J Infect Public Health; 2009; 2(3):141-6. PubMed ID: 20701874
[TBL] [Abstract][Full Text] [Related]
19. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.
Hong J; Krop LC; Johns T; Pai MP
Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138
[TBL] [Abstract][Full Text] [Related]
20. A protocol for developing a clinical practice guideline for therapeutic drug monitoring of vancomycin.
Ye ZK; Chen K; Chen YL; Zhai SD
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):469-472. PubMed ID: 27376822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
